Lunesta Missed-Dose Protocol: What to Do If You Skip Eszopiclone

Why Timing Matters More Than the Dose Itself

Eszopiclone reaches peak plasma concentration (Tmax) in about 1 hour when taken on an empty stomach, and its terminal elimination half-life averages 6 hours in healthy adults [1]. That pharmacokinetic profile means the drug is still circulating at clinically meaningful levels 7 to 8 hours after ingestion. Taking a dose at 2 a.m. when your alarm is set for 6 a.m. leaves only 4 hours, which places residual sedation squarely in your morning commute window.

The FDA addressed this concern directly in a 2014 safety communication, recommending that patients who take sedative-hypnotics should not drive or engage in activities requiring full alertness the morning after use, particularly if they did not get a full night of sleep [2]. For eszopiclone specifically, the prescribing information states that the drug should be taken "immediately before bedtime" with "at least 7 to 8 hours remaining before the planned time of awakening" [1]. That language is the foundation of every missed-dose decision.

A single skipped dose of a short-to-intermediate-acting hypnotic does not produce withdrawal. Rebound insomnia, the phenomenon where sleep quality temporarily worsens after stopping a sedative, typically requires several consecutive nights of use followed by abrupt cessation. The Krystal et al. 6-month trial (N=788) found no evidence of rebound insomnia on the first two nights after discontinuation of eszopiclone 3 mg, with wake-after-sleep-onset (WASO) values returning to baseline rather than exceeding it [3].

The 7-to-8-Hour Rule Explained

The core protocol is simple. If you realize you missed your dose, check the clock. Count the hours between now and your planned wake time. If 7 or more hours remain, take the dose. If fewer than 7 hours remain, skip it entirely and resume your regular dose the following night.

This threshold is not arbitrary. It comes from the drug's pharmacokinetic elimination curve. At 7 hours post-dose, roughly 55% of the drug has been cleared (just over one half-life). By 8 hours, clearance approaches 63%. Below that window, plasma concentrations remain high enough to impair psychomotor performance. A crossover study published in the Journal of Clinical Psychopharmacology measured next-day driving simulation performance after nighttime eszopiclone 3 mg and found statistically significant lane-deviation increases when sleep duration was restricted to 4 hours compared with a full 8-hour sleep opportunity [4].

Patients on the 1 mg dose (the recommended starting dose for older adults per the American Geriatrics Society Beers Criteria) may have a slightly wider margin because lower doses produce proportionally lower peak concentrations [5]. But the 7-to-8-hour rule should still apply as a safety floor. Elderly patients metabolize eszopiclone more slowly, with mean half-life values around 9 hours in adults over 65, which actually narrows the safety margin rather than expanding it [1].

Step-by-Step Protocol for a Missed Dose

The following sequence covers the three scenarios patients encounter most often.

Scenario 1: You forgot at bedtime but it has been less than 1 hour. Take the dose. You are still within the normal dosing window, and peak absorption will occur within 60 to 90 minutes. Avoid eating a high-fat meal beforehand. A high-fat meal delays Tmax by approximately 1 hour and reduces Cmax by 21%, per the FDA label pharmacokinetic data [1].

Scenario 2: You wake at 1 or 2 a.m. and realize you never took your dose. Calculate remaining sleep time. If your alarm is set for 7 a.m. and it is currently 1 a.m., you have 6 hours remaining. That falls below the 7-hour threshold. Skip the dose. If your alarm is 8 a.m. and it is 12:30 a.m., you have 7.5 hours. Take it.

Scenario 3: You intentionally skipped a dose (travel, alcohol use, etc.). No action needed. Resume your normal dose the next night at the usual time. Do not compensate by increasing the dose. The maximum recommended nightly dose is 3 mg for adults and 2 mg for patients over 65 [1].

Never take two tablets in one night. Eszopiclone doses above 3 mg have been associated with dose-dependent increases in adverse events including dysgeusia (unpleasant metallic taste), dizziness, and next-morning somnolence in the key registration trials [6].

How Eszopiclone Works: Mechanism Relevant to Missed Doses

Understanding the drug's mechanism clarifies why the timing constraints exist. Eszopiclone is a cyclopyrrolone-class nonbenzodiazepine that binds selectively to the alpha subunit of the GABA-A receptor, specifically at the benzodiazepine binding site. It is the S-enantiomer of racemic zopiclone, with roughly twice the potency at GABA-A receptors containing the alpha-1 subunit [7].

Alpha-1-containing GABA-A receptors are concentrated in the cerebral cortex, thalamic reticular nucleus, and brainstem sleep-promoting nuclei. Binding at these receptors increases chloride conductance, hyperpolarizes the neuron, and suppresses arousal circuits. The onset is rapid. The offset depends entirely on drug clearance.

This is why a missed dose taken too late creates problems that a missed dose skipped entirely does not. The sedation is pharmacologically inevitable once the drug reaches receptor-occupying concentrations. You cannot "will through" a dose of eszopiclone that has not yet cleared your system. PET imaging studies with related Z-drugs have shown that GABA-A receptor occupancy above approximately 25 to 30% correlates with subjective sedation and measurable psychomotor impairment [8]. At 5 hours post-dose, occupancy for a 3 mg eszopiclone dose is still estimated above that threshold in most patients.

The selectivity profile also explains why eszopiclone produces less anxiolytic and muscle-relaxant activity than traditional benzodiazepines (which bind alpha-1, alpha-2, alpha-3, and alpha-5 subunits with roughly equal affinity). This reduced off-target activity is clinically relevant: a missed dose of eszopiclone is less likely to cause next-day muscle weakness or falls than a missed dose of a full benzodiazepine agonist like temazepam, though the sedative risk remains comparable [9].

Rebound Insomnia: One Missed Night vs. Stopping the Drug

Patients frequently worry that skipping a single dose will trigger a bad night. The evidence suggests otherwise. Rebound insomnia, defined as sleep parameters (latency, WASO, total sleep time) worsening beyond pre-treatment baseline after drug discontinuation, is a phenomenon associated with abrupt cessation after sustained use.

The landmark 6-month eszopiclone trial by Krystal and colleagues randomized 788 adults with primary insomnia to eszopiclone 3 mg or placebo nightly for 6 months. On the two nights following discontinuation, the eszopiclone group showed no rebound effect. Mean subjective sleep latency on the first post-discontinuation night was 37.8 minutes in the former eszopiclone group versus 36.3 minutes in the placebo group [3]. WASO returned to values statistically indistinguishable from placebo. This was a notable finding because rebound had been documented with older benzodiazepine hypnotics at comparable treatment durations.

A single missed dose mid-treatment is pharmacologically different from discontinuation. You still have residual GABA-A receptor modulation from the prior night's dose tapering off over that 24-hour period. The clinical expectation is that sleep onset may take somewhat longer on the skipped night (estimates range from 10 to 25 additional minutes based on the latency data in [3]), but this does not constitute rebound.

Dr. Andrew Krystal, now at the University of California San Francisco Department of Psychiatry, stated in a 2019 review of Z-drug discontinuation outcomes: "The absence of rebound insomnia with eszopiclone, even after six months of nightly use, distinguishes it pharmacologically from shorter-acting benzodiazepine receptor agonists" [10].

Special Populations and Adjusted Thresholds

Older adults (65+). The starting and maximum dose is 1 to 2 mg. Half-life extends to approximately 9 hours [1]. The practical implication: the minimum remaining sleep window should be 8 to 9 hours, not 7. The American Geriatrics Society 2023 Beers Criteria lists all nonbenzodiazepine hypnotics as potentially inappropriate in older adults due to fall risk, delirium, and fractures [5]. A missed dose in this population should default to skipping.

Hepatic impairment. Eszopiclone is extensively metabolized by CYP3A4 and CYP2E1. In patients with severe hepatic impairment (Child-Pugh Class C), the AUC increases by 41% and the half-life extends substantially [1]. The FDA recommends a maximum dose of 2 mg in severe hepatic impairment. The missed-dose window should widen to 9+ hours.

Concurrent CYP3A4 inhibitors. Ketoconazole 400 mg increased eszopiclone AUC by 2.2-fold in a drug interaction study [1]. Patients taking strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir) should not exceed 2 mg and should extend their minimum sleep window. If the prescriber has not adjusted the dose, this is a conversation to have before the missed-dose question even arises.

Patients with comorbid obstructive sleep apnea. Sedative-hypnotics can worsen upper airway collapsibility. A pooled analysis of Z-drug trials found that the apnea-hypopnea index (AHI) did not significantly worsen in mild-to-moderate OSA patients on eszopiclone, but the respiratory depressant effect is dose-dependent [11]. A late-night dose in an OSA patient, taken after CPAP has been removed, adds respiratory risk on top of sedation risk. Skip the dose.

What Not to Do After Missing a Dose

Do not substitute alcohol for the missed dose. Ethanol and eszopiclone both enhance GABAergic inhibition, and the FDA label carries a specific warning against concomitant use. Co-ingestion increases CNS depression, respiratory depression risk, and next-morning impairment in a supra-additive fashion [1].

Do not take an over-the-counter antihistamine (diphenhydramine, doxylamine) as a replacement. While these drugs produce sedation through H1 receptor blockade rather than GABA modulation, their half-lives are 4 to 9 hours, and adding them creates a next-morning anticholinergic burden (dry mouth, urinary retention, confusion in elderly patients) that the prescriber likely sought to avoid by choosing eszopiclone in the first place.

Do not increase the next night's dose to "catch up." Sleep debt does not respond to higher sedative doses. The homeostatic sleep drive (Process S) will naturally increase after a short night, making the next evening's sleep onset faster without pharmacological augmentation. A meta-analysis of 13 insomnia pharmacotherapy trials confirmed that dose escalation above recommended thresholds does not proportionally improve sleep continuity but does proportionally increase adverse events [12].

When to Contact Your Prescriber

A single missed dose handled with the 7-to-8-hour rule does not require a call to your physician. However, contact your prescriber if you are missing doses frequently (3 or more times per week), as this may indicate that the medication timing or the treatment approach itself needs reassessment. Cognitive behavioral therapy for insomnia (CBT-I) remains the first-line treatment recommended by the American Academy of Sleep Medicine and produces durable improvements without the pharmacokinetic timing constraints of any sedative-hypnotic [13].

Also contact your prescriber if you took a late dose and experience next-morning drowsiness, dizziness, or impaired coordination. The FDA recommends reporting such events, as they may indicate that your personal clearance rate is slower than average and that a dose reduction or switch is warranted [2].